- Home
- EAF vs EHAB Comparison
EAF vs EHAB Comparison
Compare EAF & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EAF
- EHAB
- Stock Information
- Founded
- EAF 1886
- EHAB 2014
- Country
- EAF United States
- EHAB United States
- Employees
- EAF N/A
- EHAB N/A
- Industry
- EAF Industrial Machinery/Components
- EHAB Hospital/Nursing Management
- Sector
- EAF Energy
- EHAB Health Care
- Exchange
- EAF Nasdaq
- EHAB Nasdaq
- Market Cap
- EAF 437.2M
- EHAB 401.8M
- IPO Year
- EAF 1995
- EHAB N/A
- Fundamental
- Price
- EAF $1.46
- EHAB $8.54
- Analyst Decision
- EAF Hold
- EHAB Hold
- Analyst Count
- EAF 5
- EHAB 6
- Target Price
- EAF $1.73
- EHAB $9.20
- AVG Volume (30 Days)
- EAF 1.5M
- EHAB 268.2K
- Earning Date
- EAF 02-07-2025
- EHAB 03-05-2025
- Dividend Yield
- EAF N/A
- EHAB N/A
- EPS Growth
- EAF N/A
- EHAB N/A
- EPS
- EAF N/A
- EHAB N/A
- Revenue
- EAF $541,710,000.00
- EHAB $1,037,200,000.00
- Revenue This Year
- EAF N/A
- EHAB $0.93
- Revenue Next Year
- EAF $5.07
- EHAB $3.50
- P/E Ratio
- EAF N/A
- EHAB N/A
- Revenue Growth
- EAF N/A
- EHAB N/A
- 52 Week Low
- EAF $0.52
- EHAB $6.85
- 52 Week High
- EAF $2.53
- EHAB $11.74
- Technical
- Relative Strength Index (RSI)
- EAF 36.45
- EHAB 59.62
- Support Level
- EAF $1.50
- EHAB $7.83
- Resistance Level
- EAF $1.53
- EHAB $8.93
- Average True Range (ATR)
- EAF 0.11
- EHAB 0.28
- MACD
- EAF -0.01
- EHAB 0.06
- Stochastic Oscillator
- EAF 7.00
- EHAB 66.55
About EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two major product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.